Target intelligence / Profile preview

MicroRNA 4277 (MIR4277)

Target
MIR4277
Molecular classification
microRNA, Non-coding RNA
01

Overview

MicroRNA 4277 (MIR4277) is a non-coding RNA gene belonging to the microRNA family, located in the human genome and transcribed by RNA polymerase II[1]. Like other microRNAs, it functions to regulate gene expression at the post-transcriptional level, primarily by binding to complementary sequences on target messenger RNAs (mRNAs), leading to mRNA degradation or repression of translation[1][5]. The mature form is processed via cleavage by Drosha and Dicer ribonucleases and is loaded into an RNA-induced silencing complex (RISC) to exert its regulatory effects[1][5]. While microRNAs play broad roles in cellular regulatory networks, only limited disease association (finger agnosia) is described for MIR4277, and no validated drug interactions or clinical biomarkers are reported[1]. The class is defined by short (~20-24 nucleotide) single-stranded RNA molecules involved in gene silencing and cellular homeostasis; microRNA deregulation may be implicated in disease, but MIR4277 has few specific links to major human pathologies.

Other names
MIR4277hsa-mir-4277microRNA 4277Ensembl: ENSG00000263746NCBI Gene: 100422966HGNC: 38367
02

Biological functions

Post-transcriptional regulation of gene expressionmRNA stability and translation inhibitionPotential roles in cell proliferation, differentiation, and survival (generic to microRNAs, not specific to MIR4277)
03

Disease associations

Finger agnosia (reported disease association for MIR4277, though evidence is limited)Other roles (only in a general microRNA context; no disease association is established in cancer, inflammation, neurodegeneration, cardiovascular, or infection for MIR4277 specifically)

Beyond the preview

Go deeper on MicroRNA 4277 (MIR4277).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4277 (MIR4277).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call